Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    NEJM Interview: Dr. David Asch on why requiring informed consent for trials that pose minimal risk to participants can do more harm than good.

    NEJM Interview: Dr. David Asch on why requiring informed consent for trials that pose minimal risk to participants can do more harm than good.

    FromNEJM Interviews

    Start listeningView podcast show

    NEJM Interview: Dr. David Asch on why requiring informed consent for trials that pose minimal risk to participants can do more harm than good.

    FromNEJM Interviews

    ratings:
    Length:
    10 minutes
    Released:
    Oct 11, 2017
    Format:
    Podcast episode

    Description

    Dr. David Asch is executive director of the Center for Health Care Innovation at the University of Pennsylvania. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. D.A. Asch, T.A. Ziolek, and S.J. Mehta. Misdirections in Informed Consent - Impediments to Health Care Innovation. N Engl J Med 2017;377:1412-4.
    Released:
    Oct 11, 2017
    Format:
    Podcast episode

    Titles in the series (100)

    The New England Journal of Medicine (NEJM) Audio interview RSS feed. NEJM (http://www.nejm.org) is a weekly general medical journal that publishes new medical research findings, review articles, and editorial opinion on a wide variety of topics of importance to biomedical science and clinical practice.